Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Understanding lymphatic dysfunction in lymphedema

Official title: Study of Lymphatic Dysfunction in Primary and Secondary Lymphedema

Run by University Hospital, Toulouse · NCT05629026 · Data updated 2026-11-12

This study is trying to understand the differences in lymphatic problems between inherited and cancer-related lymphedema to find new ways to help patients feel better.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedFebruary 21, 2024
Main results expectedFebruary 2026
Study endsFebruary 2026
Registry record updatedDecember 31, 2025
Trial IDNCT05629026 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 75 who have developed primary or secondary lymphedema after breast cancer treatment.

Probably not a fit

Patients with active infections, venous insufficiency, or a history of chronic inflammatory diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the molecular and histological differences between primary and secondary lymphedema, conditions characterized by impaired lymphatic function and swelling. It aims to analyze gene expression in patients who have developed lymphedema, either inherited or as a result of cancer treatment. By utilizing micro-biopsies, the study seeks to uncover potential therapeutic strategies to restore lymphatic function. The research is conducted at the University Hospital in Toulouse, focusing on patients with specific eligibility criteria related to their lymphedema condition.

Why it matters

Potential benefit: If successful, this study could lead to new therapeutic strategies for managing lymphedema, improving patient quality of life.

How similar studies have gone: While there is limited research directly comparing primary and secondary lymphedema at the molecular level, the study's approach is novel and could provide valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients in who developed primary lymphedema or secondary lymphedema after breast cancer treatment.
2. Male and female over the age of 18 and under 75.
3. Patient affiliated to a social security scheme in France.
4. Patient having signed informed consent prior to inclusion in the study and prior to any specific procedure for the study.
5. Patients with no recidive \> 3 years after cancer surgery.
6. Patients with Body Mass Index \<35.
7. Patient enrolled in a care pathway for the management of their lymphedema (medical and educational care).
8. Patients wearing a compression orthosis on the limb with lymphedema.

Exclusion Criteria:

1. Patients with strong suspicion or with active bacterial or fungal infection.
2. Patient with venous insufficiency associated with lymphedema.
3. Patient with a history of deep venous thrombosis on the limb with lymphedema.
4. History of chronic inflammatory disease.
5. Active neoplasia during parallel management.
6. Patient already included in another therapeutic trial.
7. Pregnant or breastfeeding woman.
8. Metastatic cancer.
9. Bilateral breast cancer.
10. Obliterative arterial disease.
11. Multiple erysipelas.
12. Active smoking (delayed healing).
13. Medicines that may promote delayed healing (Corticosteroid therapy, immunosuppressants).
14. Medication that thins the blood (aspirin and antiplatelet agent, anti-coagulant).
15. Betadine allergy.
16. Patient under guardianship or trusteeship, persons placed under the protection of justice

Where it's running

  • Toulouse Hospital
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.